BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31173924)

  • 1. Resveratrol up-regulates ATP2A3 gene expression in breast cancer cell lines through epigenetic mechanisms.
    Izquierdo-Torres E; Hernández-Oliveras A; Meneses-Morales I; Rodríguez G; Fuentes-García G; Zarain-Herzberg Á
    Int J Biochem Cell Biol; 2019 Aug; 113():37-47. PubMed ID: 31173924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines.
    Contreras-Leal E; Hernández-Oliveras A; Flores-Peredo L; Zarain-Herzberg Á; Santiago-García J
    Mol Carcinog; 2016 Oct; 55(10):1477-85. PubMed ID: 26331238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors promote ATP2A3 gene expression in hepatocellular carcinoma cells: p300 as a transcriptional regulator.
    Hernández-Oliveras A; Izquierdo-Torres E; Meneses-Morales I; Rodríguez G; Zarain-Herzberg Á; Santiago-García J
    Int J Biochem Cell Biol; 2019 Aug; 113():8-16. PubMed ID: 31146004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP2A3 gene as an important player for resveratrol anticancer activity in breast cancer cells.
    Izquierdo-Torres E; Rodríguez G; Meneses-Morales I; Zarain-Herzberg A
    Mol Carcinog; 2017 Jul; 56(7):1703-1711. PubMed ID: 28150875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of the human ATP2A3 gene promoter in gastric and colon cancer cell lines.
    Meneses-Morales I; Izquierdo-Torres E; Flores-Peredo L; Rodríguez G; Hernández-Oliveras A; Zarain-Herzberg Á
    Mol Carcinog; 2019 Jun; 58(6):887-897. PubMed ID: 30657210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP2A3 gene is involved in cancer susceptibility.
    Korosec B; Glavac D; Volavsek M; Ravnik-Glavac M
    Cancer Genet Cytogenet; 2009 Jan; 188(2):88-94. PubMed ID: 19100511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.
    Ye CG; Chen GG; Ho RLK; Merchant JL; He ML; Lai PBS
    Biochim Biophys Acta; 2013 Dec; 1833(12):2970-2979. PubMed ID: 23954442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cell differentiation activates transcription of the Sarco/Endoplasmic Reticulum calcium-ATPase 3 gene (ATP2A3) in gastric and colon cancer cells.
    Flores-Peredo L; Rodríguez G; Zarain-Herzberg A
    Mol Carcinog; 2017 Feb; 56(2):735-750. PubMed ID: 27433831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21
    Chatterjee B; Ghosh K; Kanade SR
    Biofactors; 2019 Sep; 45(5):818-829. PubMed ID: 31317586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
    Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
    Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation.
    Venza I; Visalli M; Fortunato C; Ruggeri M; Ratone S; Caffo M; Caruso G; Alafaci C; Tomasello F; Teti D; Venza M
    Epigenetics; 2012 Nov; 7(11):1315-30. PubMed ID: 23051921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells.
    Xu S; Ren J; Chen HB; Wang Y; Liu Q; Zhang R; Jiang SW; Li J
    Curr Pharm Des; 2014; 20(11):1881-7. PubMed ID: 23888960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
    Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
    J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
    Tryndyak VP; Kovalchuk O; Pogribny IP
    Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional repression of ER through hMAPK dependent histone deacetylation by class I HDACs.
    Plotkin A; Volmar CH; Wahlestedt C; Ayad N; El-Ashry D
    Breast Cancer Res Treat; 2014 Sep; 147(2):249-63. PubMed ID: 25129342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sp1-mediated epigenetic dysregulation dictates HDAC inhibitor susceptibility of HER2-overexpressing breast cancer.
    Li G; Xie Q; Yang Z; Wang L; Zhang X; Zuo B; Zhang S; Yang A; Jia L
    Int J Cancer; 2019 Dec; 145(12):3285-3298. PubMed ID: 31111958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of soluble guanylate cyclase (sGC) β1 in breast cancer cells.
    Sotolongo A; Mónica FZ; Kots A; Xiao H; Liu J; Seto E; Bian K; Murad F
    FASEB J; 2016 Sep; 30(9):3171-80. PubMed ID: 27279362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.
    To SQ; Takagi K; Miki Y; Suzuki K; Abe E; Yang Y; Sasano H; Simpson ER; Knower KC; Clyne CD
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):331-8. PubMed ID: 22929011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.